For: | Sheng L, Li J, Qi BT, Ji YQ, Meng ZJ, Xie M. Investigation on correlation between expression of CD58 molecule and severity of hepatitis B. World J Gastroenterol 2006; 12(26): 4237-4240 [PMID: 16830383 DOI: 10.3748/wjg.v12.i26.4237] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v12/i26/4237.htm |
Number | Citing Articles |
1 |
Yalu Zhang, Qiaofei Liu, Sen Yang, Quan Liao. CD58 Immunobiology at a Glance. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.705260
|
2 |
Neha Tripathi, Laurence Leherte, Daniel P. Vercauteren, Adèle D. Laurent. Structure-based identification of inhibitors disrupting the CD2–CD58 interactions. Journal of Computer-Aided Molecular Design 2021; 35(3): 337 doi: 10.1007/s10822-020-00369-z
|
3 |
Chuanzheng Wang, Fei Cao, Jiahao Cao, Zhen Jiao, Yuting You, Yu Xiong, Wenxiu Zhao, Xiaomin Wang. CD58 acts as a tumor promotor in hepatocellular carcinoma via activating the AKT/GSK-3β/β-catenin pathway. Journal of Translational Medicine 2023; 21(1) doi: 10.1186/s12967-023-04364-4
|
4 |
Ming Xie, Ping Chen, Lin-jing He, Bao-tai Qi, Ping Wang, Xiao-fang Wang, Hui-xun Ren. The detection of sLFA-3 in plasma of patients with hemorrhagic fever with renal syndrome. Clinical and Experimental Medicine 2009; 9(1): 67 doi: 10.1007/s10238-008-0007-z
|
5 |
Ping WANG, Bao-tai QI, Ping CHEN, Lin-jing HE, Jie LI, Yu-qiang JI, Ming XIE. CD58 expression of liver tissue in patients with chronic hepatitis B virus infection. Chinese Medical Journal 2008; 121(6): 557 doi: 10.1097/00029330-200803020-00018
|